Download FREE Report Sample
Download Free sampleImmunotherapy treatment methods are evolving and are one of the prime methods for the treatment of cancer. PD-1/PD-L1 inhibitors have a targeted approach and decrease toxicity and hence resulting in increased efficacy.
Pd-1 and Pd-L1 Inhibitors Market contains market size and forecasts of Pd-1 and Pd-L1 Inhibitors in global, including the following market information:
Global Pd-1 and Pd-L1 Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pd-1 and Pd-L1 Inhibitors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pd-1 and Pd-L1 Inhibitors companies in 2021 (%)
The global Pd-1 and Pd-L1 Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD-1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pd-1 and Pd-L1 Inhibitors include Bristol-Myers Squibb, Merck, F. Hoffmann-La Roche, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pd-1 and Pd-L1 Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pd-1 and Pd-L1 Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pd-1 and Pd-L1 Inhibitors Market Segment Percentages, by Type, 2021 (%)
PD-1
PD-L1
Global Pd-1 and Pd-L1 Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pd-1 and Pd-L1 Inhibitors Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
Global Pd-1 and Pd-L1 Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pd-1 and Pd-L1 Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pd-1 and Pd-L1 Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pd-1 and Pd-L1 Inhibitors revenues share in global market, 2021 (%)
Key companies Pd-1 and Pd-L1 Inhibitors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pd-1 and Pd-L1 Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Merck
F. Hoffmann-La Roche
Sanofi
Amgen
Gilead Sciences
AstraZeneca
Novartis
Pfizer
Celgene
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
